These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9212449)

  • 1. Nonpeptide angiotensin II receptor antagonists: synthesis and biological activity of 1H-imidazo and 1H-[1,2,3]-triazolo fused derivatives.
    Delgado F; Pastor J; García-Navío JL; Vaquero JJ; Alvarez-Builla J; Sunkel C; de Casa-Juana MF; Priego JG; Santos LR; Statkow PR; Straumann D
    Farmaco; 1997 Mar; 52(3):147-55. PubMed ID: 9212449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
    Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
    J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Substituted anilino imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity.
    Corona P; Vitale G; Loriga M; Paglietti G; La Colla P; Collu G; Sanna G; Loddo R
    Eur J Med Chem; 2006 Sep; 41(9):1102-7. PubMed ID: 16828932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
    Ashton WT; Cantone CL; Chang LL; Hutchins SM; Strelitz RA; MacCoss M; Chang RS; Lotti VJ; Faust KA; Chen TB
    J Med Chem; 1993 Mar; 36(5):591-609. PubMed ID: 8496939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors.
    Alam MS; Huang J; Ozoe F; Matsumura F; Ozoe Y
    Bioorg Med Chem; 2007 Aug; 15(15):5090-104. PubMed ID: 17544280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.
    Sircar I; Winters RT; Quin J; Lu GH; Major TC; Panek RL
    J Med Chem; 1993 Jun; 36(12):1735-45. PubMed ID: 8510101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
    J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Merighi S; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(14):4697-701. PubMed ID: 16000006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.
    Catarzi D; Colotta V; Varano F; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Montopoli C; Moro S
    J Med Chem; 2005 Dec; 48(25):7932-45. PubMed ID: 16335918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Minetti P; Tinti MO; Carminati P; Castorina M; Di Cesare MA; Di Serio S; Gallo G; Ghirardi O; Giorgi F; Giorgi L; Piersanti G; Bartoccini F; Tarzia G
    J Med Chem; 2005 Nov; 48(22):6887-96. PubMed ID: 16250647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
    J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
    Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological investigation of novel 4-(2-methylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents.
    Alagarsamy V; Rupeshkumar M; Kavitha K; Meena S; Shankar D; Siddiqui AA; Rajesh R
    Eur J Med Chem; 2008 Nov; 43(11):2331-7. PubMed ID: 18031870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as potential adenosine receptor antagonists.
    Pastorin G; Bolcato C; Cacciari B; Kachler S; Klotz KN; Montopoli C; Moro S; Spalluto G
    Farmaco; 2005 Apr; 60(4):299-306. PubMed ID: 15848204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.
    Colotta V; Catarzi D; Varano F; Calabri FR; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Deflorian F; Moro S
    J Med Chem; 2004 Jul; 47(14):3580-90. PubMed ID: 15214785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and antibacterial activity of 3-(4-piperazin-1-yl-phenyl)-s-triazolo [3,4-b] [1,3,4] thiadiazole hydrochlorides].
    Hu GQ; Sun MF; Xie SQ; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2007 Jan; 42(1):54-7. PubMed ID: 17520807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation.
    Agelis G; Resvani A; Matsoukas MT; Tselios T; Kelaidonis K; Kalavrizioti D; Vlahakos D; Matsoukas J
    Amino Acids; 2011 Feb; 40(2):411-20. PubMed ID: 20607324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
    J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands.
    Okamura T; Kurogi Y; Hashimoto K; Nishikawa H; Nagao Y
    Bioorg Med Chem Lett; 2004 May; 14(10):2443-6. PubMed ID: 15109629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.